Review of Prostate Anatomy and Embryology and the Etiology of Benign Prostatic Hyperplasia.
Aaron L, Franco OE, Hayward SW.
Urol Clin North Am. 2016 Aug;43(3):279-88. doi: 10.1016/j.ucl.2016.04.012.
Management of Benign Prostatic Hyperplasia.
Kim EH, Larson JA, Andriole GL.
Annu Rev Med. 2016;67:137-51. doi: 10.1146/annurev-med-063014-123902. Epub 2015 Sep 2.
Benign prostate hyperplasia and nutrition.
Das K, Buchholz N.
Clin Nutr ESPEN. 2019 Oct;33:5-11. doi: 10.1016/j.clnesp.2019.07.015. Epub 2019 Aug 12.
Benign prostatic hyperplasia - what do we know?
Devlin CM, Simms MS, Maitland NJ.
BJU Int. 2021 Apr;127(4):389-399. doi: 10.1111/bju.15229. Epub 2020 Sep 24.
Benign Prostatic Hyperplasia.
Langan RC.
Prim Care. 2019 Jun;46(2):223-232. doi: 10.1016/j.pop.2019.02.003. Epub 2019 Apr 1.
Management of benign prostate hyperplasia: an overview of alpha-adrenergic antagonist.
Garg G, Singh D, Saraf S, Saraf S.
Biol Pharm Bull. 2006 Aug;29(8):1554-8. doi: 10.1248/bpb.29.1554.
Benign prostate hyperplasia: a review of the year's progress from bench to clinic.
Donnell RF.
Curr Opin Urol. 2011 Jan;21(1):22-6. doi: 10.1097/mou.0b013e32834100dd.
Clinical value of prostate segmentation and volume determination on MRI in benign prostatic hyperplasia.
Garvey B, Türkbey B, Truong H, Bernardo M, Periaswamy S, Choyke PL.
Diagn Interv Radiol. 2014 May-Jun;20(3):229-33. doi: 10.5152/dir.2014.13322.
Commentary on the Article "Systematic Review and Meta-Analysis Comparing Prostatic Artery Embolisation to Gold-Standard Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia".
Abt D, Zumstein V, Hechelhammer L.
Cardiovasc Intervent Radiol. 2021 Feb;44(2):194-195. doi: 10.1007/s00270-020-02706-z. Epub 2020 Nov 17.
Morphogenesis of nodular hyperplasia--prostate.
Pradhan BK, Chandra K.
J Urol. 1975 Feb;113(2):210-3. doi: 10.1016/s0022-5347(17)59446-x.
